Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1982 2
1983 1
1984 3
1985 1
1987 1
1988 1
1989 3
1990 3
1991 11
1992 4
1993 1
1994 4
1995 2
1996 6
1997 5
1998 7
1999 4
2000 10
2001 11
2002 4
2003 14
2004 9
2005 11
2006 10
2007 13
2008 10
2009 13
2010 15
2011 16
2012 25
2013 28
2014 16
2015 26
2016 22
2017 31
2018 26
2019 21
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

350 results
Results by year
Filters applied: . Clear all
Page 1
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial
Shitara K, et al. Lancet Oncol 2018 - Clinical Trial. Among authors: Alsina M. PMID 30355453
Patients were randomly assigned (2:1) via dynamic randomisation from a centralised interactive voice-response system to receive either oral trifluridine/tipiracil (35 mg/m(2) twice daily on days 1-5 and days 8-12 every 28 days) plus best supportive care or placebo plus best supportive care. ...
Patients were randomly assigned (2:1) via dynamic randomisation from a centralised interactive voice-response system to receive either oral …
How I treat gastric adenocarcinoma
Alsina M, et al. ESMO Open 2019 - Review. PMID 31354966 Free PMC article.
Weekly carfilzomib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A phase 1b study
Biran N, et al. Am J Hematol 2019. Among authors: Alsina M. PMID 31021005 Free PMC article.
Median carfilzomib dose was 53.2 mg/m(2) (56-mg/m(2) group) and 62.4 mg/m(2) (70-mg/m(2) group). Grade ≥3 AE rates were 70.0% (56 mg/m(2) ) and 69.6% (70 mg/m(2) ). Overall response rates were 90.0% (56 mg/m(2) ) and 89.1% (70 mg/m(2) ); ≥very good partial response rates were 50.0% (56 mg/m(2) ) and 73.9% (70 mg/m(2) ). ...
Median carfilzomib dose was 53.2 mg/m(2) (56-mg/m(2) group) and 62.4 mg/m(2) (70-mg/m(2) group). Grade ≥3 AE rat …
350 results
Jump to page
Feedback